Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SYN - Synthetic Biologics Inc. (SYN) CEO Steven Shallcross on Q4 2021 Results - Earnings Call Transcript

SYN - Synthetic Biologics Inc. (SYN) CEO Steven Shallcross on Q4 2021 Results - Earnings Call Transcript

Synthetic Biologics Inc.
Synthetic Biologics, Inc. (SYN) Q4 2021 Earnings Conference Call March 16, 2022 16:30 ET CompanyParticipants Chris Calabrese - LifeSci Advisors, IR Steven Shallcross - Chief Executive Officer & Chief Financial Officer Manel Cascallo - General Director of VCN & European Operations Frank Tufaro - Head of Operations of VCN Conference Call Participants Jim Molloy - Alliance Global Partners Jason McCarthy - Maxim Group Michael Okunewitch - Maxim Group Presentation Operator Greetings and welcome to the Synthetic Biologics Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn this conference over to your host, Mr. Chris Calabrese with LifeSci Advisors. Thank you, sir. You may begin. Chris Calabrese Thank you, operator and good afternoon, everyone. Welcome to the

For further details see:

Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Synthetic Biologics Inc.
Stock Symbol: SYN
Market: NYSE
Website: syntheticbiologics.com
Menu
SYN SYN Quote SYN Short SYN News SYN Articles SYN Message Board
Get SYN Alerts

News, Short Squeeze, Breakout and More Instantly...